# Federico Franchi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/federico-franchi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,016 |
| Field | Hemodynamic Monitoring and Therapy |
| h-index | 41 |
| i10-index | 102 |
| Last Known Institution | University of Siena |
| OpenAlex ID | https://openalex.org/A5066912546 |
| ORCID iD | 0000-0002-4448-1892 |
| Works | 359 |

## Researcher papers

- [Mapping the human genetic architecture of COVID-19](https://scholariq.org/papers/mapping-the-human-genetic-architecture-of-covid-19/)
- [Whole-genome sequencing reveals host factors underlying critical COVID-19](https://scholariq.org/papers/whole-genome-sequencing-reveals-host-factors-underlying-critical-covid-19/)
- [Myocardial depression in sepsis: From pathogenesis to clinical manifestations and treatment](https://scholariq.org/papers/myocardial-depression-in-sepsis-from-pathogenesis-to-clinical-manifestations-and/)
- [ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population](https://scholariq.org/papers/ace2-gene-variants-may-underlie-interindividual-variability-and-susceptibility/)
- [A first update on mapping the human genetic architecture of COVID-19](https://scholariq.org/papers/a-first-update-on-mapping-the-human-genetic-architecture-of-covid-19/)
- [Worldwide Survey of COVID-19–Associated Arrhythmias](https://scholariq.org/papers/worldwide-survey-of-covid-19-associated-arrhythmias/)
- [Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial](https://scholariq.org/papers/tocilizumab-for-patients-with-covid-19-pneumonia-the-single-arm-tocivid-19/)
- [Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients](https://scholariq.org/papers/double-blind-group-comparative-study-of-testosterone-undecanoate-and-mesterolone/)
- [Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19](https://scholariq.org/papers/serum-kl-6-concentrations-as-a-novel-biomarker-of-severe-covid-19/)
- [Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women.](https://scholariq.org/papers/placebo-controlled-cross-over-study-of-effects-of-org-od-14-in-menopausal-women/)
- [THE SUBJECTIVE FEELING OF BURDEN IN CAREGIVERS OF ELDERLY WITH DEMENTIA: HOW TO INTERVENE?](https://scholariq.org/papers/the-subjective-feeling-of-burden-in-caregivers-of-elderly-with-dementia-how-to/)

## Researcher topics

- [Hemodynamic Monitoring and Therapy](https://scholariq.org/topics/hemodynamic-monitoring-and-therapy/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [Respiratory Support and Mechanisms](https://scholariq.org/topics/respiratory-support-and-mechanisms/)
- [Cardiac Arrest and Resuscitation](https://scholariq.org/topics/cardiac-arrest-and-resuscitation/)

## Researcher university

- [University of Siena](https://scholariq.org/institutions/university-of-siena/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
